These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6129169)

  • 21. Treatment of streptozotocin-diabetic dogs with a long-acting somatostatin analog.
    Lien EL; Greenwood J; Sarantakis D
    Diabetes; 1979 May; 28(5):491-5. PubMed ID: 437379
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of islet-activating protein (IAP), purified from the culture medium of Bordetella pertussis, on the secretion of immunoreactive insulin and glucagon in normal, alloxan-treated, and depancreatized dogs.
    Yoshida T; Nakamura Y; Nakano K; Kondo M
    Diabetes; 1981 May; 30(5):430-4. PubMed ID: 6262169
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of hypophysectomy on pancreatic islet hormone and insulin-like growth factor I content and mRNA expression in rat.
    Jevdjovic T; Maake C; Zwimpfer C; Krey G; Eppler E; Zapf J; Reinecke M
    Histochem Cell Biol; 2005 Feb; 123(2):179-88. PubMed ID: 15812646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings.
    DeFronzo RA; Sherwin RS; Dillingham M; Hendler R; Tamborlane WV; Felig P
    J Clin Invest; 1978 Feb; 61(2):472-9. PubMed ID: 621284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unresponsiveness to glucose in a streptozocin model of diabetes. Inappropriate insulin and glucagon responses to a reduction of glucose concentration.
    Leahy JL; Weir GC
    Diabetes; 1985 Jul; 34(7):653-9. PubMed ID: 2861128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic consequences of insulin deficiency].
    Lefebvre PJ; Luyckx AS; Scheen AJ; Castillo M; Jandrain B; Krzentowski G
    Journ Annu Diabetol Hotel Dieu; 1984; ():163-74. PubMed ID: 6152663
    [No Abstract]   [Full Text] [Related]  

  • 28. Arginine stimulated insulin and glucagon release from islets transplanted into the liver of diabetic rats.
    Brömme HJ; Hahn HJ; Lucke S; Hildebrandt W; Blech W
    Horm Metab Res; 1989 Nov; 21(11):587-9. PubMed ID: 2512239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin modulation of glucagon secretion and its importance in human glucose homeostasis.
    Gerich JE
    Metabolism; 1978 Sep; 27(9 Suppl 1):1283-90. PubMed ID: 682992
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of nociceptin on insulin release in normal and diabetic rat pancreas.
    Adeghate E; Saeed Z; D'Souza C; Tariq S; Kalász H; Tekes K; Adeghate EA
    Cell Tissue Res; 2018 Dec; 374(3):517-529. PubMed ID: 30112574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Giunta R; Torella R; D'Onofrio F
    Diabete Metab; 1987; 13(6):618-24. PubMed ID: 2896134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo.
    Bradley DC; Poulin RA; Bergman RN
    Diabetes; 1993 Feb; 42(2):296-306. PubMed ID: 8093879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretion of glucagon and insulin in hypophysectomized rats: effect of tolbutamide.
    Dunbar JC; Walsh MF; Foà PP
    Horm Res; 1979; 11(2):81-91. PubMed ID: 383597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relative importance of nervous system and hormones to the 2-deoxy-D-glucose-induced hyperglycemia in fed rats.
    Matsunaga H; Iguchi A; Yatomi A; Uemura K; Miura H; Gotoh M; Mano T; Sakamoto N
    Endocrinology; 1989 Mar; 124(3):1259-64. PubMed ID: 2563682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of glucagon in regulatory rather than emergency responses to hypoglycemia.
    Gauthier C; Vranic M; Hetenyi G
    Am J Physiol; 1980 Feb; 238(2):E131-40. PubMed ID: 6987894
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin, glucagon and glucose in the regeneration response of the liver.
    Caruana JA; Goldman JK; Camara DS; Gage AA
    Surg Gynecol Obstet; 1981 Nov; 153(5):626-30. PubMed ID: 6270836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potassium and endocrine pancreatic function.
    Nutr Rev; 1974 Jan; 32(1):9-12. PubMed ID: 4591578
    [No Abstract]   [Full Text] [Related]  

  • 38. Streptozotocin diabetes in the monkey: plasma levels of glucose, insulin, glucagon, and somatostatin, with corresponding morphometric analysis of islet endocrine cells.
    Jones CW; Reynolds WA; Hoganson GE
    Diabetes; 1980 Jul; 29(7):536-46. PubMed ID: 6103856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Regulation mechanism of insulin and glucagon secretion from the isolated, perfused canine pancreas by somatostatin].
    Kawai K
    Horumon To Rinsho; 1983 May; 31(5):407-13. PubMed ID: 6136354
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.